| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 2-Yr Return |
|---|---|---|---|---|---|
|
FTRE
Fortrea Holdings Inc.
|
Jun 24, 2026 | HOLD |
Buy
-11.6% avg upside
11 analysts
|
$18.00
4.62% Upside
|
· |
|
RGEN
Repligen
|
Jun 24, 2026 | BUY |
Strong Buy
+25.8% avg upside
25 analysts
|
$160.00
15.56% Upside
|
· |
|
TMO
Thermo Fisher
|
Jun 24, 2026 | BUY |
Strong Buy
+20.8% avg upside
38 analysts
|
$625.00
27.20% Upside
|
· |
|
WAT
Waters
|
Jun 24, 2026 | BUY |
Strong Buy
+0.2% avg upside
30 analysts
|
$425.00
15.13% Upside
|
· |
|
IQV
IQVIA Holdings
|
Jun 24, 2026 | BUY |
Strong Buy
+22.4% avg upside
38 analysts
|
$210.00
12.37% Upside
|
· |
|
NTRA
Natera
|
Jun 24, 2026 | BUY |
Strong Buy
-1.4% avg upside
26 analysts
|
$260.00
1.67% Downside
|
· |
|
GH
Guardant Health
|
Jun 24, 2026 | BUY |
Strong Buy
-7.7% avg upside
30 analysts
|
$150.00
9.68% Upside
|
· |
|
TWST
Twist Bioscience
|
Jun 24, 2026 | BUY |
Strong Buy
-25.4% avg upside
14 analysts
|
$95.00
4.13% Upside
|
· |
|
AVTR
Avantor
|
Jun 24, 2026 | SELL |
Buy
+48.6% avg upside
26 analysts
|
$8.00
17.24% Downside
|
· |
|
TXG
10x Genomics
|
Jun 24, 2026 | BUY |
Buy
-24.9% avg upside
18 analysts
|
$40.00
16.01% Upside
|
· |
|
SHC
Sotera Health
|
Jun 24, 2026 | BUY |
Strong Buy
+24.1% avg upside
13 analysts
|
$19.00
13.84% Upside
|
· |
|
A
Agilent
|
Jun 24, 2026 | BUY |
Strong Buy
+0.8% avg upside
32 analysts
|
$150.00
13.88% Upside
|
· |
|
BRKR
Bruker
|
Jun 24, 2026 | BUY |
Buy
-6.8% avg upside
22 analysts
|
$60.00
3.38% Upside
|
· |
|
DHR
Danaher
|
Jun 24, 2026 | BUY |
Strong Buy
+15.3% avg upside
45 analysts
|
$230.00
21.99% Upside
|
· |
|
ICLR
Icon
|
Jun 24, 2026 | HOLD |
Strong Buy
+17.8% avg upside
25 analysts
|
$160.00
0.32% Upside
|
· |
|
ILMN
Illumina
|
Jun 24, 2026 | SELL |
Buy
-15.1% avg upside
30 analysts
|
$145.00
17.36% Downside
|
· |
|
RVTY
Revvity
|
Jun 24, 2026 | HOLD |
Buy
+0.5% avg upside
23 analysts
|
$105.00
1.18% Downside
|
+0.0% |
|
QGEN
Qiagen
|
Jun 24, 2026 | HOLD |
Buy
+9.7% avg upside
23 analysts
|
$38.00
2.23% Downside
|
· |
|
WST
West Pharmaceutical Services
|
Jun 09, 2026 | BUY |
Strong Buy
+2.4% avg upside
17 analysts
|
$400.00
16.93% Upside
|
-1.5% |
|
CRL
Charles River Labs
|
Jun 08, 2026 | BUY |
Strong Buy
+3.4% avg upside
34 analysts
|
$220.00
8.97% Upside
|
-2.2% |
|
CERT
Certara
|
May 12, 2026 | HOLD |
Buy
+137.2% avg upside
21 analysts
|
$6.50
18.66% Upside
|
+18.9% |
|
PACB
Pacific Biosciences
|
May 11, 2026 | SELL |
Buy
+206.7% avg upside
14 analysts
|
$1.50
4.44% Upside
|
+17.6% |
|
MTD
Mettler-Toledo
|
May 08, 2026 | BUY |
Buy
-1.7% avg upside
18 analysts
|
$1500.00
24.14% Upside
|
+3.5% |
|
LH
Labcorp Holdings
|
May 01, 2026 | HOLD |
Strong Buy
-1.3% avg upside
36 analysts
|
$290.00
8.54% Upside
|
+3.9% |
|
MEDP
Medpace Holdings
|
Apr 24, 2026 | HOLD |
Buy
-20.7% avg upside
16 analysts
|
$450.00
12.89% Downside
|
+12.1% |
|
DGX
Quest Diagnostics
|
Apr 22, 2026 | BUY |
Buy
-15.5% avg upside
33 analysts
|
$230.00
12.22% Upside
|
-3.1% |
|
LUMN
Lumen Technologies
|
Jun 12, 2023 | HOLD |
Hold
+43.2% avg upside
20 analysts
|
$42.00
423.01% Upside
|
+129.5% |
|
JBHT
JB Hunt
|
Jan 18, 2023 | BUY |
Strong Buy
-14.0% avg upside
31 analysts
|
$200.00
25.37% Downside
|
-5.1% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.